Risk of Nephrolithiasis Associated With SGLT2 Inhibitors Versus DPP4 Inhibitors Among Patients With Type 2 Diabetes: A Target Trial Emulation Study
We found a lower risk of nephrolithiasis associated with SGLT2is versus DPP4is in stone never- and ever-formers. Despite a greater relative risk reduction in the former, the absolute risk reduction was greater in the latter.
Authors
- Ju‐Young Shin (ORCID: https://orcid.org/0000-0003-1010-7525)
- Eun Ha Kang (ORCID: https://orcid.org/0000-0001-9697-1159)
- Anna Shin (ORCID: https://orcid.org/0000-0003-0520-8356)
Institutions
- Seoul National University Bundang Hospital (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Diabetes Care
- Published
- 2024-12-12
- DOI
- https://doi.org/10.2337/dc24-1652
- Citations
- 10
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.58
Funders
- Seoul National University Bundang Hospital
- Korea Health Industry Development Institute